Notice 2008-91: The Internal Revenue Service Moves to Facilitate Liquidity
Client Alert | 1 min read | 10.07.08
The unprecedented events of the past few weeks have resulted in numerous efforts to ease the credit crisis crippling the U.S. credit markets and the broader global economy. Domestically, the President, Congress, the Federal Reserve, banking officials, private industry and various regulators have all been involved in attempts to bolster the credit markets; as the crisis has spread, foreign counterparts have joined in the stabilization attempts as well. With its release of Notice 2008-91, the Internal Revenue Service (IRS) joins the ranks of those promoting liquidity in the credit markets.
In Notice 2008-91, filed on October 3, 2008, the IRS announced an expansion of the short-term financing exception to Internal Revenue Code (IRC) Section 956 which allows corporations to access cash from their controlled foreign corporations (CFCs) without being subject to an income inclusion for U.S. tax purposes.
Generally, a loan from a CFC to its U.S. shareholder is treated as the acquisition of an obligation of a U.S. person by the CFC that may result in income to the U.S. shareholder under IRC Section 951. Notice 88-108 provided an exception for short term loans repaid within 30 days, as long as the CFC does not hold obligations that would be investments for more than 60 days during the year. Notice 2008-91 expands the earlier Notice by providing the short term financing exception to loans that are repaid within 60 days from the time incurred, as long as the CFC does not hold obligations that would be investments in U.S. property for 180 days or more during the tax year.
The IRS explicitly indicates that the Notice is intended to facilitate liquidity in the near term. Therefore, the exclusion applies only for the first two taxable years of a foreign corporation ending after October 3, 2008. For calendar year corporations the Notice will be applicable to tax years 2008 and 2009.
Recent turmoil in the credit markets and the economic instability it promotes necessitates the pursuit of all reasonable means to increase liquidity. The release of Notice 2008-91 is an indication that the IRS is taking steps in that direction.
Insights
Client Alert | 3 min read | 05.23.25
Executive Order Seeks Most-Favored-Nation Drug Pricing and HHS Announces Price Targets
On May 12, 2025, President Trump issued an Executive Order titled "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients," which aims to reduce the costs of prescription drugs and biologics for American consumers and other payers. This Order revives a plan from President Trump’s first term and follows his April Executive Order, “Lowering Drug Prices by Once Again Putting Americans First,” which also sought to reduce drug prices. With drug prices in the United States nearly three times higher than many other countries, this second Order asks drug manufacturers to adopt Most-Favored-Nation (MFN) pricing for drugs sold in the United States or face potential regulation. MFN pricing would tether drug prices offered in the United States to the lower-cost prices offered in other comparably developed nations, such as Canada, Germany, or the United Kingdom.
Client Alert | 4 min read | 05.22.25
Opportunities for Procurement on the Horizon as UK Concludes Free Trade Agreement With India
Client Alert | 2 min read | 05.22.25
What Trump’s Nominee for IRS Commissioner Could Mean for Employee Retention Tax Credit Enforcement
Client Alert | 3 min read | 05.20.25